Randomized trial finds both proton and photon therapies preserve post-treatment well-being
The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report…
Post-operative radiation therapy reduces pelvic relapse in high-risk bladder cancer
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive…
Proton therapy and IMRT show similar outcomes in head and neck cancer trial
A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in…
AI tool accurately distinguishes between glioblastoma and primary central nervous system lymphoma
A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike…
This $0.05 Pill Could Revolutionize Colon Cancer Treatment
A major clinical trial led by Swedish researchers has revealed that a common, inexpensive drug could play a…
Genetic testing guides personalized radiation patients with HPV-positive throat cancer
Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according to…
UCLA presents advances in radiation therapy at ASTRO 2025
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results…
Philips new CT and MR systems at ASTRO 2025
Philips expands MR leadership with helium-free BlueSeal RT [4] Alongside its newest CT innovations, Philips is introducing…
“Junk DNA” Provides Surprising New Treatments for Hard-To-Treat Blood Cancers
Researchers at King’s College London have uncovered a surprising vulnerability in certain blood cancers by targeting a part…
Leading cancer organizations call for action to boost HPV vaccine coverage
VCU Massey Comprehensive Cancer Center, along with 61 other National Cancer Institute (NCI)-Designated Cancer Centers, several leading national…
Regular mammograms linked to longer survival in women over 80
For many older women, the question of whether to continue breast cancer screening has been uncertain. While most…
Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC Cancer
Despite therapeutic advancements, the prognosis for metastatic ccRCC remains poor, with a 5-year survival rate of approximately 12–20…